1. Aguilar L, Rosendo J, Balcabao IP, et al. Pharmacodynamic effects of Amoxicillin versus Cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study. Antimicrob Agents Chemother 1997; 41 (6): 1389-91. 2. Lister PD, Pong A, Chartrand SA, et al. Rationale behind high-dose Amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. Antimicrob Agents Chemother 1997: 1926-32. 3. Hoberman A, Paradise JL, Block S, et al. Efficacy of Amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996; 15 (10): 955-62. 4. Nahler G, Otupal R. Tratamiento de infecciones ORL y del tracto respiratorio con Amoxicilina dos y tres veces al día. Sumario de recientes estudios clínicos. Congreso Internacional de Enfermedades Infecciosas El Cairo, 20-24 Abril, 1985. 5. Fenoll A, Casal J, Giménez MJ, et al. Short-term bactericidal activity of Amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation. J Chemother 2000; 12 (2): 124-8. 6. Pukander JS, Jero JP, Kaprio EA, Sorri MJ. Clarithromycin vs. Amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J 1993; 12 (12 Suppl 3): S118-21. 7. Aguilar A, Tinoco JC, Macias M, et al. Clinical and bacteriologic efficacy of Amoxycillin b.d. (45 mg/kg/day) versus Amoxycillin t.d.s. (40 mg/kg/day) in children with group A beta-hemolytic streptococcal tonsillopharyngitis. J Chemother 2000; 12 (5): 396-405. 8. Valtonen M, Piippo T, Pitkajarvi T, Pyykonen ML. Comparison of Amoycillin given two and three times a day in acute respiratory tract infections in children. Scand J Prim Health Care 1986; 4 (4): 201-4. 9. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6 (5): 592-9.